Tips for Pharmaceutical Manufacturing Scale-Up & Tech Transfer

The initial signs of complications during the scale-up from lab to pilot scale were detected when batches in the pilot phase demonstrated variability in quality attributes. During routine testing, discrepancies…

During the pilot batch development phase, operators reported unusual viscosity changes of the fermentation broth that were not observed during lab scale testing. Quality control (QC) personnel detected deviations in…

Identifying symptoms or signals on the production floor or in the laboratory is crucial for early detection of issues during the tech transfer from lab to pilot scale. Common signs…

During the tech transfer from lab to pilot scale, certain signals can indicate underlying problems. Common symptoms include:Click to read the full article.

As a pharmaceutical professional, recognizing the telltale signs of discrepancies between lab and pilot equipment is the first step in addressing potential quality issues. Common symptoms include:Click to read the…

When transitioning from lab to pilot scale, various symptoms may emerge that signal quality issues. These may manifest as:Click to read the full article.

Identifying symptoms or signals during the transition from lab to pilot scale is the first step in avoiding pitfalls during scale-up. Observations and data trends can provide immediate indicators of…

Strategies for Reviewing Pilot Scale Batch Trends Before Scaling to Commercial Production As pharmaceutical professionals, transitioning from a lab scale to pilot scale can present a multitude of challenges. Identifying…

The following are common symptoms that indicate potential issues during pilot scale manufacturing:Click to read the full article.

The initial indicators that may suggest problems when scaling from lab to pilot production are critical for timely intervention. Common symptoms include:Click to read the full article.

In our case study, a cutting-edge biopharmaceutical company faced unexpected fluctuations in yield during a pilot batch development meant to validate a new biologic drug. The batch, intended to be…

Preventing Surprises in Scale-Up from Lab to Pilot Batch Production Scaling up pharmaceutical processes from lab to pilot scale presents inherent challenges that can lead to unexpected outcomes. In this…